Innovation Pharmaceuticals Inc (IPIX)
OTHER OTC:IPIX
US Market
Holding IPIX?
Track your performance easily

Innovation Pharmaceuticals (IPIX) Income Statement

131 Followers

Innovation Pharmaceuticals Income Statement

Last quarter (Q ), Innovation Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Innovation Pharmaceuticals's net income was $-880.00K. See Innovation Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 23Jun 22Jun 21Jun 20Jun 19
Total Revenue
--$ 18.00K-$ 423.00K-
Cost of Revenue
------
Gross Profit
--$ 18.00K-$ 423.00K-
Operating Expense
$ 2.36M$ 2.94M$ 6.92M$ 9.02M$ 5.06M$ -6.45M
Operating Income
$ -2.56M$ -3.11M$ -6.92M$ -9.02M$ -4.63M$ -8.68M
Net Non Operating Interest Income Expense
$ -902.00K$ 57.00K$ 115.00K$ -4.86M$ -208.00K$ -1.80M
Other Income Expense
$ -475.00K$ -172.00K$ -168.00K$ -506.00K$ 1.85M$ 33.00K
Pretax Income
$ -609.00K$ -3.17M$ -7.04M$ -18.73M$ -8.71M$ -19.20M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
$ -139.00K$ -172.00K$ -22.00K---
Net Income Common Stockholders
$ -2.62M$ -3.17M$ -7.04M$ -13.87M$ -6.65M$ -19.20M
Basic EPS
$ -34.99--$ -0.04$ -0.03-
Diluted EPS
$ -34.99--$ -0.04$ -0.03$ -0.05
Basic Average Shares
$ 19.46K$ 19.46K$ 58.39K$ 386.16M$ 237.30M$ 178.23M
Diluted Average Shares
$ 19.46K$ 19.46K$ 58.39K$ 386.16M$ 237.30M$ 338.04M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 2.58M$ 2.94M$ 6.78M$ 9.02M$ 5.06M$ -6.45M
Net Income From Continuing And Discontinued Operation
$ -2.62M$ -3.17M$ -7.04M$ -13.87M$ -6.65M$ -19.20M
Normalized Income
-$ -1.86M$ -5.56M$ -14.80M--
Interest Expense
------
EBIT
$ -1.88M$ -3.11M$ -6.93M$ -9.02M$ -6.39M$ -17.39M
EBITDA
$ -1.60M$ -2.74M$ -6.54M$ -8.64M$ -6.01M$ -17.02M
Currency in USD

Innovation Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis